These results underscore the correlation between tau pathology and cognitive decline in clinical settings, suggesting that tau pathology may be more closely associated with cognitive impairment, a hallmark of Alzheimer's disease.[9]. The gene discussed is MAPT; the disease is Cognitive impairment.